Frank van Engelenburg
Frank is Managing Consultant at Progress PME and joined the company in March 2017.
Frank is an experienced CMC Leader and has successfully led numerous CMC projects ranging from early development projects to late stage development and for MAA/BLA. In his role as CMC Leader he has been responsible for meeting quality aspects of different biologics, CMC development strategy, CMC regulatory strategy, and for CMC planning and budget control.
Frank holds a PhD in virology and was trained as a molecular biologist. After his PhD he worked as a senior scientist as Sanquin for 11 years and subsequently joined Kinesis-Pharma (Currently Venn) as senior consultant CMC for 10 years.
- Viral safety of biologics
- Efficient and effective drug development of biological products
- Technical due diligence for in licencing opportunities of biologicals
- CMC development of monoclonal antibodies, vaccines and gene therapy product